SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 13, 2012 BIOCUREX, INC. ---------------------------------- (Name of Small Business Issuer in its charter) Texas 0-26947 75-2742601 ---------------------------- ------------------ ------------------ (State or other jurisdiction (Commission File No.) (IRS Employer of incorporation) Identification No.) 7080 River Road, Suite 215 Richmond, British Columbia , Canada V6X 1X5 ------------------------------------------------ (Address of Principal Executive Offices, including Zip Code) Registrant's telephone number, including area code: (866) 884-8669 N/A ------------------------------------------ (Former name or former address if changed since last report)
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer; Compensatory Arrangements of Certain Officers. On June 13, 2012, Mr. Trent Davis, President of Paulson Investment Company, Inc. ("PIC"), resigned as a director of the Company. Mr. Davis' resignation was not due to any disagreement with the Company on any matter relating to the Company's operations, policies or practices. Instead, given the possibility of strategic transactions between PIC and the Company, Mr. Davis determined that it was in the best interests of PIC for him to resign as a Company director in order to eliminate the potential of any conflicting affiliations between PIC and the Company, including with respect to a $150,000 loan by PIC to the Company. 2
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 18, 2012 BIOCUREX, INC. By:/s/ Ricardo Moro ------------------------------------- Dr. Ricardo Moro, President 3